Cargando…
Fermented Mistletoe Extract as a Multimodal Antitumoral Agent in Gliomas
In Europe, commercially available extracts from the white-berry mistletoe (Viscum album L.) are widely used as a complementary cancer therapy. Mistletoe lectins have been identified as main active components and exhibit cytotoxic effects as well as immunomodulatory activity. Since it is still not el...
Autores principales: | Podlech, Oliver, Harter, Patrick N., Mittelbronn, Michel, Pöschel, Simone, Naumann, Ulrike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3485514/ https://www.ncbi.nlm.nih.gov/pubmed/23133496 http://dx.doi.org/10.1155/2012/501796 |
Ejemplares similares
-
Adjuvant Therapy Using Mistletoe Containing Drugs Boosts the T-Cell-Mediated Killing of Glioma Cells and Prolongs the Survival of Glioma Bearing Mice
por: Schötterl, Sonja, et al.
Publicado: (2018) -
Mistletoe-Based Drugs Work in Synergy with Radio-Chemotherapy in the Treatment of Glioma In Vitro and In Vivo in Glioblastoma Bearing Mice
por: Schötterl, Sonja, et al.
Publicado: (2019) -
The standardized mistletoe preparation Lektinol has antitumoral potencies
por: Mengs, U, et al.
Publicado: (2001) -
Difficulties and Perspectives of Immunomodulatory Therapy with Mistletoe Lectins and Standardized Mistletoe Extracts in Evidence-Based Medicine
por: Hajtó, Tibor, et al.
Publicado: (2011) -
Survival of Cancer Patients Treated with Non-Fermented Mistletoe
Extract: A Systematic Review and Meta-Analysis
por: Loef, Martin, et al.
Publicado: (2022)